These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 36916370)

  • 21. Lung Transplant Outcomes for Idiopathic Pulmonary Fibrosis: Are We Improving?
    Anderson S; Reck Dos Santos P; Langlais B; Campany M; Donato B; D'Cunha J
    Ann Thorac Surg; 2024 Apr; 117(4):820-827. PubMed ID: 37625610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood lipid profiles as a prognostic biomarker in idiopathic pulmonary fibrosis.
    Oh JH; Chae G; Song JW
    Respir Res; 2024 Jul; 25(1):285. PubMed ID: 39026259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic Biomarkers of Survival in Idiopathic Pulmonary Fibrosis.
    Oldham JM; Huang Y; Bose S; Ma SF; Kim JS; Schwab A; Ting C; Mou K; Lee CT; Adegunsoye A; Ghodrati S; Pugashetti JV; Nazemi N; Strek ME; Linderholm AL; Chen CH; Murray S; Zemans RL; Flaherty KR; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1111-1120. PubMed ID: 37847691
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessment of the impact of social deprivation, distance to hospital and time to diagnosis on survival in idiopathic pulmonary fibrosis.
    Shankar R; Hadinnapola CM; Clark AB; Adamali H; Chaudhuri N; Spencer LG; Wilson AM
    Respir Med; 2024 Jun; 227():107612. PubMed ID: 38677526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
    Ruan P; Todd JL; Zhao H; Liu Y; Vinisko R; Soellner JF; Schmid R; Kaner RJ; Luckhardt TR; Neely ML; Noth I; Porteous M; Raj R; Safdar Z; Strek ME; Hesslinger C; Palmer SM; Leonard TB; Salisbury ML
    Respir Res; 2023 May; 24(1):141. PubMed ID: 37344825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Body mass Index does not impact long-term survival of patients with idiopathic pulmonary fibrosis undergoing lung transplantation.
    Lushaj EB; DeCamp MM; Maloney J; Leverson G; De Oliveira N; McCarthy D
    Front Transplant; 2023; 2():1146779. PubMed ID: 38993923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
    O'Dwyer DN; Kim JS; Ma SF; Ranjan P; Das P; Lipinski JH; Metcalf JD; Falkowski NR; Yow E; Anstrom K; Dickson RP; Huang Y; Gilbert JA; Martinez FJ; Noth I
    Am J Respir Crit Care Med; 2024 May; 209(9):1101-1110. PubMed ID: 38051927
    [No Abstract]   [Full Text] [Related]  

  • 28. Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Steger M; Canuet M; Enache I; Goetsch T; Labani A; Meyer L; Martin G; Kessler R; Montani D; Riou M
    Respir Med; 2024; 225():107585. PubMed ID: 38479707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Endotypes of Idiopathic Pulmonary Fibrosis: A Latent Class Analysis of Two Multicenter Observational Cohorts.
    Maddali MV; Moore AR; Sinha P; Newton CA; Kim JS; Adegunsoye A; Ma SF; Strek ME; Chen CH; Linderholm AL; Zemans RL; Moore BB; Wolters PJ; Martinez FJ; Rogers AJ; Raj R; Noth I; Oldham JM
    Am J Respir Crit Care Med; 2024 Aug; 210(4):455-464. PubMed ID: 38913573
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis.
    Gialamas I; Arvanitaki A; Rosenkranz S; Wort SJ; Rådegran G; Badagliacca R; Giannakoulas G
    J Heart Lung Transplant; 2024 Sep; 43(9):1383-1394. PubMed ID: 38744353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The preventative effects of statin on lung cancer development in patients with idiopathic pulmonary fibrosis using the National Health Insurance Service Database in Korea.
    Lee YJ; Kang N; Nam J; Lee EG; Ryoo J; Kwon SS; Kim YH; Kang HS
    PLoS One; 2024; 19(3):e0299484. PubMed ID: 38478558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of early mortality after lung transplantation for idiopathic pulmonary arterial hypertension.
    Girgis RE; Manandhar-Shrestha NK; Krishnan S; Murphy ET; Loyaga-Rendon R
    Pulm Circ; 2024 Apr; 14(2):e12371. PubMed ID: 38646412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Valve Surgery on the Safety and Cardiac Function of Patients with Valvular Heart Disease Complicated by Pulmonary Arterial Hypertension.
    Li S; Chen Z; Li K; Zhang Z; Zhou Y
    Altern Ther Health Med; 2024 Apr; ():. PubMed ID: 38607223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signals and signposts: Biomarkers in IPF and PAH at the crossroads of clinical relevance.
    Sullivan DI; Kass DJ
    Respirology; 2019 Nov; 24(11):1044-1045. PubMed ID: 31486582
    [No Abstract]   [Full Text] [Related]  

  • 35. Body Mass Index and Cause-Specific Mortality after Lung Transplantation in the United States.
    Anderson MR; Cantu E; Shashaty M; Benvenuto L; Kalman L; Palmer SM; Singer JP; Gallop R; Diamond JM; Hsu J; Localio AR; Christie JD
    Ann Am Thorac Soc; 2023 Jun; 20(6):825-833. PubMed ID: 36996331
    [No Abstract]   [Full Text] [Related]  

  • 36. PCSK6 and Survival in Idiopathic Pulmonary Fibrosis.
    Oldham JM; Allen RJ; Lorenzo-Salazar JM; Molyneaux PL; Ma SF; Joseph C; Kim JS; Guillen-Guio B; Hernández-Beeftink T; Kropski JA; Huang Y; Lee CT; Adegunsoye A; Pugashetti JV; Linderholm AL; Vo V; Strek ME; Jou J; Muñoz-Barrera A; Rubio-Rodriguez LA; Hubbard R; Hirani N; Whyte MKB; Hart S; Nicholson AG; Lancaster L; Parfrey H; Rassl D; Wallace W; Valenzi E; Zhang Y; Mychaleckyj J; Stockwell A; Kaminski N; Wolters PJ; Molina-Molina M; Banovich NE; Fahy WA; Martinez FJ; Hall IP; Tobin MD; Maher TM; Blackwell TS; Yaspan BL; Jenkins RG; Flores C; Wain LV; Noth I
    Am J Respir Crit Care Med; 2023 Jun; 207(11):1515-1524. PubMed ID: 36780644
    [No Abstract]   [Full Text] [Related]  

  • 37. Multiple Biomarkers Are Equivalent to Clinical Pulmonary Arterial Hypertension Survival Risk Models.
    Griffiths M; Simpson CE; Yang J; Vaidya D; Nies MK; Brandal S; Damico R; Hassoun P; Ivy DD; Austin ED; Pauciulo MW; Lutz KA; Martin LJ; Rosenzweig EB; Benza RL; Nichols WC; Manlhiot C; Everett AD
    Chest; 2024 Aug; ():. PubMed ID: 39154795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive factors of mortality in patients with idiopathic pulmonary fibrosis treated with antifibrotics: a novel prognostic scoring system.
    Polat G; Özdemir Ö; Ermin S; Serçe Unat D; Demirci Üçsular F
    Sarcoidosis Vasc Diffuse Lung Dis; 2024 Jun; 41(2):e2024021. PubMed ID: 38940720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schistosomiasis-associated pulmonary arterial hypertension: survival in endemic area in Brazil.
    Piscoya Roncal CG; Mendes AA; Muniz MTC; de Oliveira SA; do Valle Neto LM; de Vasconcellos Piscoya NA; Góes GHB; Sobral Filho DC; Gomberg-Maitland M
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100373. PubMed ID: 31720370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New predictors of outcome in idiopathic pulmonary arterial hypertension.
    Kawut SM; Horn EM; Berekashvili KK; Garofano RP; Goldsmith RL; Widlitz AC; Rosenzweig EB; Kerstein D; Barst RJ
    Am J Cardiol; 2005 Jan; 95(2):199-203. PubMed ID: 15642552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.